[go: up one dir, main page]

Mbugua, 2020 - Google Patents

Synthesis, Structure Elucidation and Reactivity of Palladium (Ii) and Platinum (Ii) Complexes for Anticancer Applications

Mbugua, 2020

View PDF
Document ID
18011743229167216417
Author
Mbugua S
Publication year

External Links

Snippet

The objective of the work was to come up with stable metal complexes with bulky ligands coordinated to the metal center and test them in anticancer studies. Literature reports that bulky ligands and trans geometry for palladium and platinum complexes may produce …
Continue reading at erepository.uonbi.ac.ke (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0073—Rhodium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/06—Cobalt compounds
    • C07F15/065—Cobalt compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System

Similar Documents

Publication Publication Date Title
Patra et al. The medicinal chemistry of ferrocene and its derivatives
Haribabu et al. Water-soluble mono-and binuclear Ru (η6-p-cymene) complexes containing indole thiosemicarbazones: Synthesis, DFT modeling, biomolecular interactions, and in vitro anticancer activity through apoptosis
Zhang et al. Advances in the design of organometallic anticancer complexes
Mu et al. Activation by oxidation: ferrocene-functionalized Ru (II)-arene complexes with anticancer, antibacterial, and antioxidant properties
Ramakrishnan et al. Ternary dinuclear copper (II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5, 6-dmp ligand enhances DNA binding and cleavage and induces apoptosis
Katsaros et al. Rhodium and its compounds as potential agents in cancer treatment
Ma et al. DNA binding and cytotoxicity of ruthenium (II) and rhenium (I) complexes of 2-amino-4-phenylamino-6-(2-pyridyl)-1, 3, 5-triazine
Kostova Platinum complexes as anticancer agents
Pérez et al. New acridine thiourea gold (I) anticancer agents: Targeting the nucleus and inhibiting vasculogenic mimicry
Jeyalakshmi et al. Coordination behavior of N, N′, N ″-trisubstituted guanidine ligands in their Ru–arene complexes: synthetic, DNA/protein binding, and cytotoxic studies
Gukathasan et al. Cyclometalated Gold (III) complexes bearing DACH ligands
Panchangam et al. Antitumor effects of Ir (III)-2 H-indazole complexes for triple negative breast cancer
Brissos et al. Highly cytotoxic ruthenium (II)-arene complexes from bulky 1-pyrenylphosphane ligands
Chylewska et al. Metallopharmaceuticals in therapy-a new horizon for scientific research
Shahsavari et al. Fluorinated cycloplatinated (II) complexes bearing bisphosphine ligands as potent anticancer agents
Giovagnini et al. Chemical and biological profiles of novel copper (II) complexes containing S-donor ligands for the treatment of cancer
Zanvettor et al. Copper (II), palladium (II) and platinum (II) complexes with 2, 2-thiophen-yl-imidazole: Synthesis, spectroscopic characterization, X-ray crystallographic studies and interactions with calf-thymus DNA
Nahaei et al. Half-sandwich cyclometalated RhIII complexes bearing thiolate ligands: biomolecular interactions and in vitro and in vivo evaluations
Thanigachalam et al. Bioactive O^ N^ O^ Schiff base appended homoleptic titanium (iv) complexes: DFT, BSA/CT-DNA interactions, molecular docking and antitumor activity against HeLa and A549 cell lines
Al-Janabi et al. Spectroscopic, biological activity studies, and DFT calculations, of Pd (II) and Pt (II) complexes of 4-Methylene-3-phenyl-3, 4-dihydroquinazoline-2 (1H)-thione
Pan et al. Development of anticancer activity of the Pt (II) complex with N-heterocyclic amine: its in vitro pharmacokinetics with thiol and thio-ethers, DNA and BSA binding, and cell cycle arrest
Schoch et al. A strategy to conjugate bioactive fragments to cytotoxic diiron bis (cyclopentadienyl) complexes
Lu et al. Increasing the cytotoxicity of Ru (II) polypyridyl complexes by tuning the electron-donating ability of 1, 10-phenanthroline ligands
Mbugua Synthesis, Structure Elucidation and Reactivity of Palladium (Ii) and Platinum (Ii) Complexes for Anticancer Applications
Welsh et al. Selective Targeting of Regulated Rhabdomyosarcoma Cells by Trinuclear Ruthenium (II)–Arene Complexes